Reflections on the Collaborative Fight Against COVID-19

Michel Goldman; Mitchell Silva

doi:10.3389/fmed.2020.00565

Reflections on the Collaborative Fight Against COVID-19

Front Med (Lausanne). 2020 Sep 17:7:565. doi: 10.3389/fmed.2020.00565. eCollection 2020.

Authors

Michel Goldman¹, Mitchell Silva²

Affiliations

¹ Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.
² EUPATI Belgium vzw, Brussels, Belgium.

Abstract

Clinical trials to identify efficient treatments against COVID-19 flourish worldwide without much attention to patients' voice so far. As therapeutic interventions in the early phase of the disease are attracting more and more interest, we argue that now is the time to involve patients' organizations in the design of clinical protocols in order to define the most relevant end-points and assess the risk-benefit balance of new therapies.

Keywords: COVID-19; partnership; patient; regulation; trial.